End of Life Treatment Preferences of Latino Medicare Beneficiaries With Cancer

NCT01389830 | Unknown

• 2 other identifiers: 2011-04367K01CA151785-02
• Study Type: observational
• Target: 230
• Locations: 1 country
• Sites: 1

Brief Summary

Objectives: The primary objective of the research project is to investigate how declining health status influences the end-of-life (EOL) treatment preferences in Latino Medicare beneficiaries with cancer and to examine if and how these preferences are modified by predisposing characteristics (i.e., acculturation, education, medical mistrust, perceived racism) and/or provider-related characteristics (i.e., ethnicity, language used, provision of interpreters, or patient navigators). The specific aims are:

1. 1.To determine if declining functional status influences the end-of-life treatment preferences of older Latino Medicare beneficiaries with cancer.
2. 2.To determine if predisposing characteristics (i.e., acculturation, age, education, medical mistrust, perceived racism) and/or provider-related characteristics (i.e., ethnicity, language used, provision of interpreters, or patient navigators) modify the association between end-of-life treatment preferences and declining health status in older Latino Medicare beneficiaries with cancer.
3. 3.To identify if the end-of-life treatment preferences of Latino Medicare beneficiaries with cancer differ from those of older Medicare beneficiaries without cancer.

Conditions

Advanced Cancers

Keywords

End of Life; EOL; Latinos; Hispanic American; Medicare beneficiaries; stage III diagnosis; Breast cancer; Colorectal cancer; Prostate cancer; Lung cancer; Cancer Prevention and Treatment Demonstration; CPTD

Outcome Measures

Primary Outcomes (1)

• End of Life Treatment Preferences of Older Latinos With and Without Cancer (Survey Responses)

  Survey of how changes in functional status influence End of Life (EOL) treatment preferences among older Latinos with cancer. EOL treatment preferences treated as a continuous variable (0-10) and functional status assessed using Patient-reported Eastern Cooperative Oncology Group (ECOG) Performance Scale where low functional status will be defined as an ECOG score of 3 or 4 and high as 0-2.

  Once a month for 12 months

Study Arms (2)

Older Latinos With Cancer

Monthly Telephone Survey of Cohort with stage III or greater of breast, colorectal, or prostate cancer up until 12 months.

Behavioral: Telephone Survey

Older Latinos Without Cancer

Single Telephone Survey of Cohort without a history of cancer.

Behavioral: Telephone Survey

Interventions

Telephone Survey BEHAVIORAL

Telephone interviews (survey) at baseline taking approximately 30-40 minutes to complete; follow-up monthly surveys for cancer patients take 20-30 minutes to complete, follow ups until 12 months or death.

Also known as: Interviews

Older Latinos With Cancer; Older Latinos Without Cancer

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Survey of 200 older Latino Medicare beneficiaries from the greater Houston area enrolled in a larger national Cancer Prevention and Treatment Demonstration Project (CPTD).

You may not qualify if:

• Participants refuse to participate in the study or are not competent to give informed consent.
• Participants who miss 3 or more answers on the Six-Item Screener to Identify Cognitive Impairment.
• Participants are not able to complete the baseline assessment forms.

Sponsors & Collaborators

• M.D. Anderson Cancer Center: lead
• National Cancer Institute (NCI): collaborator

Study Sites (1)

University of Texas MD Anderson Cancer Center

Houston, Texas, 77030, United States

Location

Related Links

• University of Texas MD Anderson Cancer Center Website

MeSH Terms

Conditions

Death; Disease; Breast Neoplasms; Colorectal Neoplasms; Prostatic Neoplasms; Lung Neoplasms

Interventions

Interviews as Topic

Condition Hierarchy (Ancestors)

Pathologic Processes; Pathological Conditions, Signs and Symptoms; Neoplasms by Site; Neoplasms; Breast Diseases; Skin Diseases; Skin and Connective Tissue Diseases; Intestinal Neoplasms; Gastrointestinal Neoplasms; Digestive System Neoplasms; Digestive System Diseases; Gastrointestinal Diseases; Colonic Diseases; Intestinal Diseases; Rectal Diseases; Genital Neoplasms, Male; Urogenital Neoplasms; Genital Diseases, Male; Genital Diseases; Urogenital Diseases; Prostatic Diseases; Male Urogenital Diseases; Respiratory Tract Neoplasms; Thoracic Neoplasms; Lung Diseases; Respiratory Tract Diseases

Intervention Hierarchy (Ancestors)

Data Collection; Epidemiologic Methods; Investigative Techniques; Health Care Evaluation Mechanisms; Quality of Health Care; Health Care Quality, Access, and Evaluation; Public Health; Environment and Public Health

Study Officials

• Isabel Torres, MPH, DRPH

  M.D. Anderson Cancer Center

  STUDY CHAIR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: July 6, 2011
• First Posted: July 8, 2011
• Study Start: June 30, 2011
• Primary Completion: June 30, 2022
• Study Completion: June 30, 2022
• Last Updated: July 18, 2019

Record last verified: 2019-07

Locations

US (1)